Executive Summary
This digest covers $518.9 million in HHS contracts awarded between 2014 and 2022, with zero defense-related exposure. The dominant theme is NIH facility and research spending, led by a $302.1 million Whiting-Turner construction contract for Building 10 renovation, which accounts for 58% of total value and signals steady institutional infrastructure demand.
The highest-conviction signal is a bullish $48.8 million award to PRECISE FEDERAL CONSULTING LLC, a small, women-owned business with multiple set-aside certifications, indicating policy-driven growth in HHS training programs. Key risks include the Whiting-Turner contract nearing its September 2024 end date, which may create re-compete uncertainty, and the nonprofit status of three recipients (Harvard, MRIGLOBAL, PRECISE FEDERAL) limiting direct equity investment opportunities. Overall, the digest reveals a civilian-focused, low-tech, stable procurement environment with limited public company exposure beyond Booz Allen Hamilton's $58.3 million CDC IT services contract.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior All HHS Contracts digest from July 10, 2026.
Investment Signals (3)
- PRECISE FEDERAL CONSULTING LLC Secures $48.8M HHS/CMS Training Contract with Set-Aside Advantages (MEDIUM)▲
The cost-plus-fixed-fee structure reduces execution risk, and the company's 8(a), women-owned, and minority-owned certifications provide a competitive moat for future HHS awards, signaling policy-driven growth in small business set-asides.
- Booz Allen Hamilton's $58.3M CDC DCIPHER Contract Provides Stable Civilian IT Revenue (HIGH)▲
The firm-fixed-price delivery order through 2027 offers multi-year visibility, but at $14.6M annual revenue it is immaterial to Booz Allen's ~$10B top line, reinforcing its role as a steady, not transformative, federal IT player.
- Whiting-Turner's $302M NIH Contract Nears End Date, Creating Re-Compete Uncertainty (MEDIUM)▲
The contract ends September 2024 with only $165M outlayed (55% complete), raising execution risk if scope changes or delays occur; a re-compete could introduce new competitors for NIH facility work.
Risk Flags (3)
- Execution [MEDIUM RISK]▼
Whiting-Turner's $302M NIH renovation is only 55% complete with a September 2024 deadline, creating potential for delays, cost overruns, or modifications that could affect margins.
- Concentration [MEDIUM RISK]▼
Three of five contracts (Harvard, MRIGLOBAL, PRECISE FEDERAL) are with non-profits or private entities, limiting direct investment avenues and concentrating value in entities not accessible to public equity investors.
- Budget [LOW RISK]▼
The $57.3M Harvard and $52.4M MRIGLOBAL contracts are tied to NIH/NIEHS basic research, which faces potential volatility from annual appropriations and political shifts in research funding priorities.
Opportunities (2)
- ◆
PRECISE FEDERAL CONSULTING LLC's $48.8M HHS/CMS training contract, combined with its 8(a) and women-owned certifications, positions it for follow-on awards as HHS expands surveyor training programs under healthcare oversight mandates.
- ◆
Booz Allen Hamilton's $58.3M CDC DCIPHER contract for IT systems design could expand if CDC increases public health data infrastructure spending post-pandemic, with options worth up to $67.7M.
Sector Themes (2)
- ◆
The $302M Whiting-Turner contract for Building 10 renovation underscores sustained NIH investment in its Bethesda campus, a trend likely to continue as aging federal research facilities require upgrades.
- ◆
PRECISE FEDERAL CONSULTING LLC's $48.8M award, leveraging multiple set-aside certifications, highlights HHS's commitment to small, disadvantaged businesses for training and support services, a trend that may accelerate under current administration priorities.
Watch List (3)
- 👁
{"entity"=>"Whiting-Turner Contracting Company", "reason"=>"Its $302M NIH contract ends September 2024; re-compete or extension will signal NIH construction spending trajectory.", "trigger"=>"Contract end date (September 2024) or modification announcement"}
- 👁
{"entity"=>"Booz Allen Hamilton", "reason"=>"CDC DCIPHER options worth $9.4M could be exercised, providing incremental revenue visibility in civilian IT.", "trigger"=>"Option exercise announcement or CDC IT budget release"}
- 👁
{"entity"=>"PRECISE FEDERAL CONSULTING LLC", "reason"=>"As a private small business with multiple set-asides, any IPO, acquisition, or major new award would create public market exposure.", "trigger"=>"IPO filing, acquisition news, or new HHS set-aside contract award"}
Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 5 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: All HHS Contracts
🇺🇸 More from United States
View all →July 17, 2026
US Pre-Market SEC Filings Roundup — July 17, 2026
US Pre-Market SEC Filings Roundup
July 17, 2026
USA Insider Trading Pulse — July 17, 2026
USA Insider Trading Pulse
July 17, 2026
S&P 500 Financials Sector SEC Filings — July 17, 2026
S&P 500 Financials Sector SEC Filings
July 17, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — July 17, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings